Đang chuẩn bị liên kết để tải về tài liệu:
Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Current opinions on whether surgical patients with cervical cancer should undergo para-aortic lymphadenectomy at the same time are inconsistent. The present study examined differences in survival outcomes with or without para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer. |

TÀI LIỆU LIÊN QUAN

How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease - decision analysis and comparison of three international patient populations

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: A SEER population-based analysis

Comparison of survival of patients with metastases from known versus unknown primaries: Survival in metastatic cancer

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study

Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: Long-term oncological outcome analysis in 37 Chinese hospitals

Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy

Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer

Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: A propensity score matching study

Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016

Báo cáo y học: " Landmark survival as an end-point for trials in critically ill patients – comparison of alternative durations of follow-up: an exploratory analysis"
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.